LOGIN / SKAPA KONTO
Aktuellt
SUMMARY Many preventable respiratory hazards are both a cause and a consequence of climate change. Fine particulate matter, especially from wildfires and indoor sources, poses serious health risks and disproportionately affects vulnerable populations. Targeted...
SUMMARY Some get off to a bad start, others simply do not realize they have a disease. And others fall into the trap of thinking that tobacco exposure could be too low to cause...
SUMMARY Lifelong exposure to environmental factors — especially air pollution — significantly affects the risk and progression of chronic lung diseases, and understanding these interactions is key for early intervention and personalized prevention strategies....
SUMMARY In modern care, patients are expected to be empowered and to actively participate in decision making regarding their own healthcare. And on top, they are expected to make informed decisions, which for some patients require...
SUMMARY Women are more affected by asthma in adulthood and increasingly by COPD. Sex hormones influence immune responses in asthma, with estrogen and testosterone affecting inflammation through distinct receptor pathways. Should biological sex guide...
SUMMARY This was the resounding message from a recent international panel moderated by Dr. Liz Steve, a UK-based health psychologist, at the ERS Congress 2025. The session brought together patient advocates and clinical experts...
SUMMARY Are eosinophils in COPD truly a marker of type 2 (T2) inflammation, or do they simply reflect underlying or misclassified asthma? Presentation COPD: pathobiological features supporting the case for a T2 trait Speaker:...
A preview of new insights into COPD and comorbidities SUMMARY Global leading researchers —strongly represented by the Nordics—presented compelling findings on chronic obstructive pulmonary disease (COPD) and its complex interplay with cardiovascular, metabolic, genetic,...
Clinical remission in adults with moderate-to-severe asthma SUMMARY A new framework from Professor Celeste Porsbjerg’s team redefines remission in severe asthma by focusing on disease activity, not damage. Early, targeted treatment during the “at-risk...
SUMMARY Do patients with greater knowledge manage their disease better? This question was addressed in a cross sectional study presented at ERS2025. A new framework from Professor Celeste Porsbjerg’s team redefines remission in severe...
Chiesi on vuonna 1935 perustettu perheomisteinen lääkeyritys. Uskomme innovaatioihin, vastuullisuuteen ja ihmisten empatiaan. Intohimomme on parantaa potilaiden elämänlaatua maailmanlaajuisesti tutkimuksen, kehityksen ja kestävien ratkaisujen avulla.
© 2026 Chiesi Pharma AB omistaa tämän sivuston tekijänoikeudet ja pidättää kaikki oikeudet siihen.